1.         Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019; 322(2):153-60. doi:10.1001/jama.2019.9052

2.         Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018; 14(5):301-16. doi:10.1038/nrendo. 2018.18

3.         Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550-62. doi:10.1016/S0140-6736(17)30703-1

4.         Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71(16):1781-96. doi:10.1016/j.jacc.2018.02.045

5.         Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets. 2020; 20(6):836-45. doi:10.2174/1871530320666200129115536

6.         Cappola AR, Desai AS, Medici M, et al. Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment. Circulation. 2019; 139(25):2892-909. doi:10.1161/CIRCULATIONAHA.118.036859

7.         Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med. 2017; 376(26):2534-44. doi:10.1056/NEJMoa1603825

8.         Berta E, Lengyel I, Halmi S, et al. Dyslipidemia in subclinical hypothyroidism: a systematic review and meta-analysis. Endocr Pract. 2021;27(6):608-15. doi:10.1016/j.eprac.2021.02.011

9.         Qari FA. Thyroid hormone profile in patients with acute coronary syndrome. Iran Red Crescent Med J. 2015;17(7):e26919. doi:10.5812/ircmj.26919

10.      Jabbar A, Pingitore A, Pearce SHS, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. doi:10.1038/nrcardio.2016.174

11.      Jabbar A, Ingoe L, Junejo S, et al. Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial. JAMA. 2020; 324(3):249-58. doi:10.1001/jama.2020.9389

12.      Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017; 376(26):2556-65. doi:10.1056/NEJMcp1611144

13.      Izkhakov E, Zahler D, Rozenfeld KL, et al. Unknown subclinical hypothyroidism and in-hospital outcomes and short- and long-term all-cause mortality among ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Clin Med. 2020; 9(12):3829. doi:10.3390/jcm9123829

14.      Collet TH, Bauer DC, Cappola AR, et al. Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab. 2014; 99(10):3353-62. doi:10.1210/jc.2014-1255

15.      Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019; 40(3):237-69. doi:10.1093/eurheartj/ehy462

16.      Birjandi B, Ramezani Tehrani F, Amouzegar A, Tohidi M, Bidhendi Yarandi R, Azizi F. The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study: Tehran thyroid study (TTS). BMC Endocr Disord. 2021; 21(1):108. doi:10.1186/s12902-021-00773-y

17.      Buske M, Feistritzer HJ, Jobs A, Thiele H. Management of acute coronary syndrome: ESC guidelines 2023. Herz. 2024; 49(1):5-14. doi:10.1007/s00059-023-05231-8

18.      Charach L, Blatt A, Jonas M, et al. The Gensini score was used to estimate the severity of STEMI, NSTEMI, unstable angina, and anginal syndrome. Medicine (Baltimore). 2021; 100(41):e27331. doi:10.1097/MD.0000000000027331

19.      Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017; 10(3):215-23. doi:10.1016/j.jcin.2016.11.059

20.      Sun B, Liu J, Yin H, et al. Delayed vs. immediate stenting in STEMI with a high thrombus burden: a systematic review and meta-analysis. Herz. 2019; 44(8):726-34. doi:10.1007/s00059-018-4731-x

21.      Khot UN, Jia G, Moliterno DJ, et al. Prognostic importance of Killip class in acute myocardial infarction: an updated meta-analysis. J Am Coll Cardiol. 2023; 81(8_Suppl):1873. doi:10.1016/S0735-1097(23)02217-6

22.      Han C, Xu K, Wang L, et al. Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. Clin Endocrinol (Oxf). 2022; 96(1):70-81. doi:10.1111/cen. 14613

23.      Arambam P, Kaul U, Gupta S, Alok A, Kumar S, Janardhanan R. Thyroid dysfunction in acute coronary syndrome and its prognostic implications. Int J Health Sci. 2022;6(S9):2235-48. doi:10.53730/ijhs.v6nS9.12915

24.      Jabbar A, Ingoe L, Thomas H, et al. Prevalence, predictors, and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study. J Endocrinol Invest. 2021; 44(6):1209-18. doi:10.1007/s40618-020-01408-0

25.      Mavai M, Bhandari B, Singhal A, Mathur SK. Cardiac autonomic modulation and anti-thyroid Peroxidase (TPO) antibodies in subclinical hypothyroidism: does a correlation exist? Cureus. 2021; 13(10):e18844. doi:10.7759/cureus. 18844

26.      Isailă OM, Stoian VE, Fulga I, Piraianu AI, Hostiuc S. The relationship between subclinical hypothyroidism and carotid intima-media thickness as a potential marker of cardiovascular risk: a systematic review and meta-analysis. J Cardiovasc Dev Dis. 2024; 11(4):98. doi:10.3390/jcdd11040098

27.      Tan Q, Chen M, Yang H, Guo Y, Zou X. Subclinical hypothyroidism predicted adverse cardiovascular events in patients with ejection fraction preserved heart failure. Ther Clin Risk Manag. 2024; 20:227-37. doi:10.2147/TCRM.S433489

28.      Kaushik A, Agrawal M. Relationship between subclinical hypothyroidism and the risk of cardiovascular complications. Cureus. 2023; 15(1):e33708. doi:10.7759/cureus. 33708

29.      Moon S, Kim MJ, Yu JM, et al. Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid. 2018; 28(9):1101-10. doi:10.1089/thy. 2017.0414

30.      Al-Gburi AJ, Al-Obaidi SR, Abdullah WH. Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention. Ghana Med J. 2023; 57(1):37-42. doi:10.4314/gmj.v57i1.6

31.      Xu C, Zhou L, Wu K, et al. Abnormal glucose metabolism and insulin resistance are induced via the IRE1α/XBP-1 pathway in subclinical hypothyroidism. Front Endocrinol (Lausanne). 2019; 10:303. doi:10.3389/fendo.2019.00303

32.      Liu J, Duan Y, Fu J, Wang G. Association between subclinical hypothyroidism and coronary heart disease: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021; 12:642609. doi:10.3389/fendo.2021.642609

33.      Rotondi M, de Martinis L, Coperchini F, et al. Serum concentrations of acute-phase proteins in patients with autoimmune thyroiditis: a systematic review. Thyroid. 2020; 30(10):1413-20. doi:10.1089/thy. 2019.0788

34.      Ter Maaten JM, Damman K, Verhaar MC, et al. Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail. 2016; 18(6):588-98. doi:10.1002/ejhf.497

35.      Zhang H, Li X, Zhang N, Tian L. Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023; 14:1083171. doi:10.3389/fendo.2023.1083171